CIK 0000771856
- Non-accelerated filer
- Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521401755
- Phone
- +1 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President bought 30,000 shares at an average $1.66 ($49,900)
- 4 Open-market buy President bought 10,000 shares at $1.70 ($17,000)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $1.70 ($3,393)
- 4 Open-market buy President bought 10,305 shares at $1.66 ($17,106)
- 4 Open-market buy Chief Executive Officer bought 7,300 shares at an average $1.67 ($12,205)
- 4 Open-market buy President bought 29,695 shares at an average $1.67 ($49,494)
- 4 Open-market buy President bought 9,537 shares at $1.66 ($15,831)
- 4 Open-market buy Chief Executive Officer bought 8,202 shares at an average $1.63 ($13,369)
- 4 Open-market buy Chief Executive Officer bought 33 shares at $1.65 ($54)
- 4 Open-market buy President bought 3,000 shares at $1.58 ($4,740)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $1.66 ($8,324)
- 4/A Derivatives Options or other derivatives
Page 7 of 13 · 245 filings